InvestorsHub Logo
icon url

Hugon

07/20/20 8:30 AM

#312960 RE: DaubersUP #312955

That’s correct. In a 200+ patient Phase 2B a SINGLE dose of Brilacidin was non-inferior (eg as good) to billion dollar blockbuster Dapto in a 7 day treatment. The anti-infective market has been horrible over the last five years—until now. New interest with something called a pandemic.

This drug is safe and powerful. People need to understand it has been tested in over 400 living humans. That’s why they can jump right into. Phase 2 trial. And will be able to skip a Phase 3 if the Phase 2 results are strong...

icon url

cybermich

07/20/20 9:25 AM

#313036 RE: DaubersUP #312955

Today's news wouldn't have the context and wouldn't be as powerful without those studies by polymedix and city/ipix.

B has the safety profile and is effective:)

Incredible PR!